Updated on 22 August 2014
US aid workers had treated Ebola patients in West Africa
Singapore: Two US aid workers who had contracted the Ebola infection while assisting victims in West Africa have been discharged, reports claimed.
Doctors from the Atlanta hospital declared that both the victims were cured and were not contagious. Dr Kent Brantly, 33, and Ms Nancy Writebol, 59, had received the experimental drug ZMapp made by Mapp Biopharmaceuticals.
"I am thrilled to be alive," said Dr Brantly while addressing a press conference. He added that he never imagined himself in this position as a part of the medical missionary.
Dr Bruce Ribner, director, Atlanta hospital said, "Ahead of a rigorous course of treatments and tests, both patients have recovered completely of Ebola virus and can reunite with their families."
Dr Brantly urged people to continue praying for the West African families scrambling with the deadly blood borne virus. He also insisted that people with leadership and influence must put in extraordinary efforts to end the outbreak.
Dr Ribner confirmed that both the aid workers had received the experimental drug ZMapp. However, he said that it was unclear as to whether the recovery could be attributed to the drug. Dr Ribner said that the hospital would share information on the treatment and care received by the two patients among the medical community.
He emphasized that Dr Brantly and Ms Writebol were no longer contagious and probably could also be immune to the Zaire strain of the virus that they had contracted.